Patent Pending
Zynava's AI-powered supplement technology is protected by a provisional patent application filed with the United States Patent and Trademark Office (USPTO).
U.S. Provisional Patent Application
What This Patent Covers
Our provisional patent application covers the proprietary AI-powered system that powers Zynava's core tools, including:
- The AI-driven supplement plan builder that personalizes recommendations based on lifestyle, diet, and budget
- Multi-factor user preference scoring for supplement matching
- The supplement label analysis system that reads and evaluates product labels from photos
- Cross-retailer price comparison and product aggregation technology
- The AI chat advisor system for supplement questions and wellness guidance
Why This Matters
Filing a patent application with the USPTO demonstrates our commitment to innovation and our belief that the technology powering Zynava represents a genuinely novel approach to supplement guidance. We've invested significant time and resources into developing an AI system that is unique in this space.
This application protects the original methods and systems we've created, ensuring that the technology behind Zynava remains a trustworthy, independent platform that puts users first.
Important Notice
"Patent Pending" means a provisional patent application has been filed and is under review. It does not mean a patent has been granted. The provisional application establishes a priority filing date and provides 12 months to file a non-provisional (utility) patent application.
Any unauthorized use, reproduction, or imitation of Zynava's patented technology may be subject to legal action. For questions regarding our intellectual property, please contact us at business@zynava.com.